Exposure–response model for sibutramine and placebo: suggestion for application to long-term weight-control drug development
Seunghoon Han,1,2 Sangil Jeon,1,2 Taegon Hong,1,2 Jongtae Lee,1,2 Soo Hyeon Bae,1,2 Wan-su Park,1,2 Gab-jin Park,1,2 Sunil Youn,1,2 Doo Yeon Jang,1,2 Kyung-Soo Kim,3 Dong-Seok Yim1,2 1Department of Pharmacology, College of Medicine, The Catholic University of Korea, 2Pharmacometrics Institute for Pr...
Saved in:
Main Authors: | Han S (Author), Jeon S (Author), Hong T (Author), Lee J (Author), Bae SH (Author), Park WS (Author), Park G (Author), Youn S (Author), Jang DY (Author), Kim KS (Author), Yim DS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer
by: Park G, et al.
Published: (2017) -
Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects
by: Hong T, et al.
Published: (2015) -
Toxicity of sibutramine hydrochloride-adulterated weight loss supplements in rats based on biochemical and organ weight parameters
by: Suparmi Suparmi, et al.
Published: (2024) -
EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY
by: T. Yu. Demidova, et al.
Published: (2022) -
CORRIGENDUM: "EVALUATION OF WEIGHT REDUCTION EFFICACY AND SAFETY OF SIBUTRAMIN-CONTAINING DRUGS IN PATIENTS WITH ALIMENTARY OBESITY"
by: T. Yu. Demidova, et al.
Published: (2022)